140 related articles for article (PubMed ID: 15956257)
1. Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity.
He SJ; Stevens G; Braithwaite AW; Eccles MR
Mol Cancer Ther; 2005 Jun; 4(6):996-1003. PubMed ID: 15956257
[TBL] [Abstract][Full Text] [Related]
2. PAX3 is expressed in human melanomas and contributes to tumor cell survival.
Scholl FA; Kamarashev J; Murmann OV; Geertsen R; Dummer R; Schäfer BW
Cancer Res; 2001 Feb; 61(3):823-6. PubMed ID: 11221862
[TBL] [Abstract][Full Text] [Related]
3. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival.
Muratovska A; Zhou C; He S; Goodyer P; Eccles MR
Oncogene; 2003 Sep; 22(39):7989-97. PubMed ID: 12970747
[TBL] [Abstract][Full Text] [Related]
4. The E3 ligase APC/C(Cdh1) promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth.
Cao J; Dai X; Wan L; Wang H; Zhang J; Goff PS; Sviderskaya EV; Xuan Z; Xu Z; Xu X; Hinds P; Flaherty KT; Faller DV; Goding CR; Wang Y; Wei W; Cui R
Sci Signal; 2015 Sep; 8(392):ra87. PubMed ID: 26329581
[TBL] [Abstract][Full Text] [Related]
5. Increased cytotoxicity of cisplatin in SK-MEL 28 melanoma cells upon down-regulation of melanoma inhibitor of apoptosis protein.
Mousavi-Shafaei P; Ziaee AA; Zangemeister-Wittke U
Iran Biomed J; 2009 Jan; 13(1):27-34. PubMed ID: 19252675
[TBL] [Abstract][Full Text] [Related]
6. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
Vachtenheim J; Novotná H
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
[TBL] [Abstract][Full Text] [Related]
7. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
8. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
[TBL] [Abstract][Full Text] [Related]
9. p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis.
de Belle I; Huang RP; Fan Y; Liu C; Mercola D; Adamson ED
Oncogene; 1999 Jun; 18(24):3633-42. PubMed ID: 10380885
[TBL] [Abstract][Full Text] [Related]
10. Differential PAX3 functions in normal skin melanocytes and melanoma cells.
Medic S; Rizos H; Ziman M
Biochem Biophys Res Commun; 2011 Aug; 411(4):832-7. PubMed ID: 21802410
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cells.
Bartlett D; Boyle GM; Ziman M; Medic S
PLoS One; 2015; 10(4):e0124154. PubMed ID: 25880082
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes.
Tatzel J; Poser I; Schroeder J; Bosserhoff AK
Pigment Cell Res; 2005 Apr; 18(2):92-101. PubMed ID: 15760338
[TBL] [Abstract][Full Text] [Related]
13. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.
Raffo AJ; Kim AL; Fine RL
Oncogene; 2000 Dec; 19(54):6216-28. PubMed ID: 11175336
[TBL] [Abstract][Full Text] [Related]
14. Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.
Taylor AC; Schuster K; McKenzie PP; Harris LC
Mol Cancer; 2006 Nov; 5():53. PubMed ID: 17081294
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
Sasaki H; Sheng Y; Kotsuji F; Tsang BK
Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.
Zanon M; Piris A; Bersani I; Vegetti C; Molla A; Scarito A; Anichini A
Cancer Res; 2004 Oct; 64(20):7386-94. PubMed ID: 15492260
[TBL] [Abstract][Full Text] [Related]
17. c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells.
Biroccio A; Benassi B; Amodei S; Gabellini C; Del Bufalo D; Zupi G
Mol Pharmacol; 2001 Jul; 60(1):174-82. PubMed ID: 11408612
[TBL] [Abstract][Full Text] [Related]
18. EGR-1 induction is required for maximal radiosensitivity in A375-C6 melanoma cells.
Ahmed MM; Venkatasubbarao K; Fruitwala SM; Muthukkumar S; Wood DP; Sells SF; Mohiuddin M; Rangnekar VM
J Biol Chem; 1996 Nov; 271(46):29231-7. PubMed ID: 8910582
[TBL] [Abstract][Full Text] [Related]
19. PAX3 across the spectrum: from melanoblast to melanoma.
Medic S; Ziman M
Crit Rev Biochem Mol Biol; 2009 Jun; 44(2-3):85-97. PubMed ID: 19401874
[TBL] [Abstract][Full Text] [Related]
20. BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53.
Basma H; El-Refaey H; Sgagias MK; Cowan KH; Luo X; Cheng PW
J Biomed Sci; 2005 Dec; 12(6):999-1011. PubMed ID: 16228292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]